{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:09:28Z","timestamp":1788916168003,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":602,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1046\/j.1365-2230.2000.00628.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:59:09Z","timestamp":1047376749000},"page":"250-254","source":"Crossref","is-referenced-by-count":49,"title":["Topical tacrolimus in dermatology"],"prefix":"10.1093","volume":"25","author":[{"given":"I. S.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB1|cit1","unstructured":"Reynolds JEF. Martindale. The Extra Pharmacopoia 31st edn 1996: 599 600"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0733-8635(18)30385-1","article-title":"A review and update of the clinical uses of cyclosporine in dermatology","volume":"9","author":"Groisser","year":"1992","journal-title":"Dermatol Clin"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000247460","article-title":"Clinical controversy on the effect of topical ciclosporin: What is the target site?","volume":"185","author":"Surber","year":"1992","journal-title":"Dermatology"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000247133","article-title":"Topical FK506 - clinical potential or laboratory curiosity?","volume":"188","author":"Lauerma","year":"1994","journal-title":"Dermatology"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199008023230502","article-title":"Effect of topical cyclosporine rinse on oral lichen planus: a double-blind analysis","volume":"323","author":"Eisen","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1990.tb08248.x","article-title":"Topical cyclosporine and psoriasis","volume":"122","author":"Schulze","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB7|cit7","first-page":"2713","article-title":"FK506: historical perspectives","volume":"23","author":"Goto","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB8|cit8","first-page":"74","article-title":"Tacrolimus (FK506): experience in Dermatology","volume":"5","author":"Lawrence","year":"1998","journal-title":"Dermatologic Ther"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB9|cit9","unstructured":"British National Formulary. 36th edn 1998: 380 2"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506, in vitro effects on cloned T-cell activation","volume":"139","author":"Sawada","year":"1987","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1989.tb05956.x","article-title":"Topical cyclosporin A in alopecia areata: failure of therapeutic effect due to lack of penetration","volume":"121","author":"Cowlson","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2340\/0001555572321326","article-title":"The enigma of cyclosporin A treatment for psoriasis: systemic efficacy versus topical non-responsiveness","volume":"72","author":"Mrowietz","year":"1992","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1254\/jjp.76.175","article-title":"Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC\/Nga mice","volume":"76","author":"Hiroi","year":"1998","journal-title":"Jap J Pharm"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00402225","article-title":"Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig","volume":"286","author":"Lauerma","year":"1994","journal-title":"Arch Dermatol Research"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/1523-1747.ep12456939","article-title":"Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases?","volume":"98","author":"Meingassner","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-3083.1996.tb00605.x","article-title":"Atopic dermatitis","volume":"7","author":"Bos","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2249.1995.tb05525.x","article-title":"IL-8\/IL-8 receptor expression psoriasis response systemic tacrolimus (FK506)","volume":"99","author":"Lemaster","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2230.2000.00628.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000236745","article-title":"Regulation of interleukin-5 production by peripheral blood mononucler cells from atopic patients with FK506, cyclosporin A and glucocorticoids","volume":"104","author":"Mori","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.4049\/jimmunol.160.11.5331","article-title":"Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses","volume":"160","author":"Homey","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"10.1046\/j.1365-2230.2000.00628.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial","volume":"111","author":"Reitamo","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(98)70541-9","article-title":"Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children","volume":"38","author":"Alaiti","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2133.1995.tb02691.x","article-title":"Successful treatment of resistant facial lesions of atopic dermatitis with 0.1 % FK506 ointment","volume":"133","author":"Aoyama","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis","volume":"337","author":"Ruzicka","year":"1997","journal-title":"New Eng J Med"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-6749(98)70281-7","article-title":"A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children","volume":"102","author":"Boguniewicz","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(05)65512-2","article-title":"Tacrolimus concentrations in blood during topical treatment of atopic dermatitis","volume":"348","author":"Kawashima","year":"1996","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.134.9.1101","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study","volume":"134","author":"Zonneveld","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0140-6736(92)91757-Y","article-title":"Inhibition of contact allergy reactions by topical FK506","volume":"340","author":"Lauerma","year":"1992","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(05)78962-5","article-title":"Topical tacrolimus for pyoderma gangrenosum","volume":"351","author":"Schuppe","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2133.1997.tb03777.x","article-title":"Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model","volume":"137","author":"McElwee","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.1999.02672.x","article-title":"Erosive mucosal lichen planus: response to topical treatment with tacrolimus","volume":"140","author":"Vente","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","article-title":"Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study","volume":"132","author":"The European","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00628.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.1992.01680160065005","article-title":"Tacrolimus (FK506) - a new therapeutic agent for severe recalcitrant psoriasis","volume":"128","author":"Jegasothy","year":"1992","journal-title":"Arch Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2000.00628.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2000.00628.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2230.2000.00628.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T20:09:18Z","timestamp":1704312558000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/25\/3\/250\/6628102"}},"subtitle":["Viewpoints in dermatology \u2022 Review article"],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2230.2000.00628.x","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}